| Date Filed | Type | Description |
| 08/11/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/25/2023 |
4
| Elia Marc (Director) has filed a Form 4 on Invivyd, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.7, valued at
$85k
|
|
| 02/10/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/19/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/13/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/26/2022 |
SC 13D/A
| M28 Capital Management LP reports a 5.8% stake in Adagio Therapeutics, Inc. |
| 04/01/2022 |
3
| Elia Marc (SEE REMARKS) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 04/01/2022 |
SC 13D
| M28 Capital Management LP reports a 5.8% stake in Adagio Therapeutics, Inc. |
| 02/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/11/2022 |
SC 13G/A
| M28 Capital Management LP reports a 5.1% stake in Adagio Therapeutics, Inc. |
| 10/29/2021 |
SC 13G
| M28 Capital Management LP reports a 7.2% stake in Wave Life Sciences Ltd. |
| 10/05/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |